BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//LifeSci Events - ECPv6.15.11//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:LifeSci Events
X-ORIGINAL-URL:https://lifescievents.com
X-WR-CALDESC:Events for LifeSci Events
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20270314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20271107T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260610T080000
DTEND;TZID=America/New_York:20260610T093000
DTSTAMP:20260519T165545
CREATED:20260504T211725Z
LAST-MODIFIED:20260519T170158Z
UID:3036-1781078400-1781083800@lifescievents.com
SUMMARY:Nasus Pharma Virtual KOL Event to Discuss NS002 for the Treatment of Anaphylaxis
DESCRIPTION:Join Nasus Pharma for a virtual key opinion leader (KOL) event featuring Michael S. Blaiss\, MD (Medical College of Georgia\, Good Samaritan Health Center of Gwinnett) and Joel Brooks\, DO\, MPH (Columbia University Vagelos College of Physicians and Surgeons\, New York-Presbyterian Morgan Stanley Children’s Hospital)\, who will join company management to discuss the unmet need and current treatment landscape for anaphylaxis. \nThe event will provide an overview of Nasus Pharma and NS002\, the Company’s epinephrine intranasal powder candidate in development for the treatment of anaphylaxis. The current standard of care for anaphylaxis is the EpiPen® injection. KOLs will review NS002’s Phase 2 data showing faster and higher absorption than the EpiPen®\, demonstrating that NS002 is poised to transform the epinephrine landscape. They will also discuss the challenges of pediatric patients\, and the perspectives of practicing physicians on the need for needle-free Epinephrine. \nA live question and answer session will follow the formal presentations. Watch the webcast by clicking this link and logging in with the email address you used to register: https://lifescievents.com/event/wkp03an/.
URL:https://lifescievents.com/event/wkp03an/
LOCATION:Virtual\, Virtual
ATTACH;FMTTYPE=image/png:https://lifescievents.com/wp-content/uploads/2026/05/Nasus-Banner.png
END:VEVENT
END:VCALENDAR